| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 49710* | 2014 |
| Identification and characterization of metabolically benign obesity in humans N Stefan, K Kantartzis, J Machann, F Schick, C Thamer, K Rittig, ... Archives of internal medicine 168 (15), 1609-1616, 2008 | 1338 | 2008 |
| Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach A Floegel, N Stefan, Z Yu, K Mühlenbruch, D Drogan, HG Joost, A Fritsche, ... Diabetes 62 (2), 639-648, 2013 | 1040 | 2013 |
| Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance NF Schwenzer, F Springer, C Schraml, N Stefan, J Machann, F Schick Journal of hepatology 51 (3), 433-445, 2009 | 956 | 2009 |
| High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes B Vozarova, N Stefan, RS Lindsay, A Saremi, RE Pratley, C Bogardus, ... diabetes 51 (6), 1889-1895, 2002 | 942 | 2002 |
| Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications N Stefan, HU Häring, FB Hu, MB Schulze The lancet Diabetes & endocrinology 1 (2), 152-162, 2013 | 910 | 2013 |
| Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies N Stefan, HU Häring, K Cusi The lancet Diabetes & endocrinology 7 (4), 313-324, 2019 | 811 | 2019 |
| Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body … N Stefan, B Vozarova, T Funahashi, Y Matsuzawa, C Weyer, RS Lindsay, ... Diabetes 51 (6), 1884-1888, 2002 | 811 | 2002 |
| Causes and metabolic consequences of fatty liver N Stefan, K Kantartzis, HU Häring Endocrine reviews 29 (7), 939-960, 2008 | 737 | 2008 |
| Obesity and impaired metabolic health in patients with COVID-19 N Stefan, AL Birkenfeld, MB Schulze, DS Ludwig Nature Reviews Endocrinology 16 (7), 341-342, 2020 | 724 | 2020 |
| α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans N Stefan, AM Hennige, H Staiger, J Machann, F Schick, SM Kröber, ... Diabetes care 29 (4), 853-857, 2006 | 721 | 2006 |
| The role of hepatokines in metabolism N Stefan, HU Häring Nature Reviews Endocrinology 9 (3), 144-152, 2013 | 612 | 2013 |
| Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans N Stefan, F Schick, HU Häring Cell metabolism 26 (2), 292-300, 2017 | 533 | 2017 |
| Plasma fetuin-A levels and the risk of type 2 diabetes N Stefan, A Fritsche, C Weikert, H Boeing, HG Joost, HU Häring, ... Diabetes 57 (10), 2762-2767, 2008 | 481 | 2008 |
| Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans C Pfannenberg, MK Werner, S Ripkens, I Stef, A Deckert, M Schmadl, ... Diabetes 59 (7), 1789-1793, 2010 | 480 | 2010 |
| Global pandemics interconnected—obesity, impaired metabolic health and COVID-19 N Stefan, AL Birkenfeld, MB Schulze Nature Reviews Endocrinology 17 (3), 135-149, 2021 | 475 | 2021 |
| Adiponectin-its role in metabolism and beyond N Stefan, M Stumvoll Hormone and Metabolic Research 34 (09), 469-474, 2002 | 453 | 2002 |
| Causes, consequences, and treatment of metabolically unhealthy fat distribution N Stefan The lancet Diabetes & endocrinology 8 (7), 616-627, 2020 | 436 | 2020 |
| Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 … N Eckel, Y Li, O Kuxhaus, N Stefan, FB Hu, MB Schulze The lancet Diabetes & endocrinology 6 (9), 714-724, 2018 | 426 | 2018 |
| Plasma adiponectin concentrations in children: relationships with obesity and insulinemia N Stefan, JC Bunt, AD Salbe, T Funahashi, Y Matsuzawa, PA Tataranni The Journal of Clinical Endocrinology & Metabolism 87 (10), 4652-4656, 2002 | 423 | 2002 |
